IE 11 is not supported. For an optimal experience visit our site on another browser.

Martin Shkreli Debuts Secret Wu-Tang Album After Trump Win

The former Turing Pharmaceuticals CEO was vilified by many in 2014 for raising the price of a medication to treat HIV by 5,000 percent.
Image: Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, prepares to testify before a House Oversight and Government Reform hearing on \"Developments in the Prescription Drug Market Oversight\" on Capitol Hill in Washington
Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, prepares to testify before a House Oversight and Government Reform hearing on "Developments in the Prescription Drug Market Oversight" on Capitol Hill in Washington February 4, 2016. REUTERS/Joshua RobertsJoshua Roberts / Reuters
/ Source: The Associated Press

NEW YORK — President-elect Donald Trump's victory Tuesday has prompted embattled pharmaceutical executive Martin Shkreli to publicly debut some songs off the one-of-a-kind Wu-Tang Clan album he bought for $2 million last year.

Image: Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, prepares to testify before a House Oversight and Government Reform hearing on "Developments in the Prescription Drug Market Oversight" on Capitol Hill in Washington
Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, prepares to testify before a House Oversight and Government Reform hearing on "Developments in the Prescription Drug Market Oversight" on Capitol Hill in Washington February 4, 2016. REUTERS/Joshua RobertsJoshua Roberts / Reuters

Shkreli promised last month to release "Once Upon a Time in Shaolin" if the Republican took the White House. He made good on the plan early Wednesday by playing snippets of the album during a live Periscope video posted on Twitter. The video has since been deleted.

Related: Satirical Musical About Indicted 'Pharma Bro' Shkreli Premieres in NYC

Shkreli won an auction for the sole copy of the album last year.

The former Turing Pharmaceuticals CEO was vilified by many in 2014 for raising the price of a medication to treat HIV by 5,000 percent. He was also charged with securities fraud last year.